NSC |
Compound |
Enrichment |
Correlation |
NSC 89671 |
Ascotoxin |
0.0238174255956147 |
-0.03984642 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.024108502230778 |
0.48089708 |
NSC 144163 |
Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- |
0.024108502230778 |
0.45541617 |
NSC 164970 |
Propanedinitrile, [(3,5-dibromo-2-ethoxyphenyl)methylene]- |
0.024108502230778 |
0.33987962 |
NSC 292816 |
1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) |
0.024108502230778 |
-0.0090050579 |
NSC 375162 |
Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide |
0.024108502230778 |
0.30981538 |
NSC 58574 |
Pyrimidine, 2,4,5-trichloro-6-propyl- |
0.024108502230778 |
0.42990488 |
NSC 603084 |
2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- |
0.024108502230778 |
0.55769519 |
NSC 628949 |
Null |
0.024108502230778 |
0.37516929 |
NSC 630252 |
Null |
0.024108502230778 |
0.71860318 |